NEWS RELEASE For Information: Cari Reisinger
FOR IMMEDIATE RELEASE Cari@PRHum.com
April 11, 2008 209-736-6769
Madison, WI—The American Medical Student
Association and Kentucky Alliance of Pharmaceutical Students from the
University of Kentucky (UK) invited Kathleen Slattery-Moschkau, the filmmaker
behind the documentary Money Talks: Profits Before Patient
Safety, and a representative from a major
drug company to speak to the school’s medical students and faculty earlier this
week. Students from the groups are
working with a campus task force to revise the University’s existing pharma
relations policy and arranged to hear expert commentary from both sides of the
fence before potentially making changes later this year.
The UK pharmaceutical awareness event—Conflicts of Interest? An Examination of the
Pharmaceutical Industry’s Relationship with Healthcare—comes just as universities
across the country are banning drug companies from their campuses,
strengthening their policies on pharma freebies and implementing guidelines for
how students interact with reps. The
Universities of Stanford, Yale and Pennsylvania
now have strict policies in place. Other
medical schools, including the program at the University of Texas-Houston
where hundreds of medical students gathered last month to prompt change on
campuses nationwide, are currently working to establish their own policies.
As part of UK’s event, Slattery-Moschkau was
asked to share her insider’s perspective from the decade she spent pushing
pills for the drug industry. Based on her personal experiences, as well as
facts and commentary presented in her films on the topic, she described how
doctors are influenced by drug companies from the moment they step foot into
their first medical class and then went on to explain how the levels of
influence escalate from there.
“The drug industry is all about
‘getting ’em while they’re young’ so doctors develop certain prescribing habits
as early as possible,” said Kathleen Slattery-Moschkau. “These companies would not be spending $21
billion annually marketing to physicians and students if it didn’t work.”
Since making her debut film, Side Effects (starring Katherine Heigl)
which was based on her experiences working for two of the nation’s top drug
companies, Slattery-Moschkau has spoken to doctors, medical schools and
organizations across the country. Following Side
Effects she released the award-winning documentary Money Talks: Profits Before Patient Safety which was selected by
the American Library Association earlier this year as a notable video of 2008. Most
recently, Slattery-Moschkau launched a weekly radio program, The Kathleen Show, and a nonprofit media production
and promotion company, Be
Both ventures are focused on using entertainment to encourage people to
live better, healthier lives.
Talking Points/Story Ideas
Kathleen Slattery-Moschkau is available for
interviews and can discuss the following:
- Medical schools across the
country are banning drug reps from their campuses and instituting policies
to protect future doctors from pharma influence. Kathleen reveals the drug
industry’s ‘Get ’em while they’re young’ mentality and shares a
behind-the-scenes perspective that proves why more medical programs need
to evaluate their policies.
- What if a
doctor reached for his or her pen and wrote a prescription for a weekly
dose of blueberries? The top reasons
why a doctor’s prescription pad should be used more often to prescribe
alternative options and lifestyle changes before drugs.
- Prescription drug prices are on
the rise, and big pharma continues to spend on direct-to-consumer
marketing; what Kathleen has to say about these ads, “free” samples and
all those attractive drug reps sitting in your doctor’s office.
American Library Association picked Kathleen’s documentary, Money Talks: Profits Before Patient
Safety as a top film of 2008 and said it “should be required viewing for
anyone concerned about the complexities and failings of the American
health care system”. Find out the unsettling information that experts
share in the film.
is not always better; why consumers should think twice before popping the
latest and greatest pill on the market, the top questions everyone should
be asking their physicians, and where people can find non-biased info about
are the candidates stacking up when it comes to health care reform and
better drug industry regulation? As
a former industry insider, Kathleen shares her thoughts.